BSE Bankex Banking Sector Regulatory Filings — April 17, 2026

Board meeting on April 27, 2026 to approve Q4/FY26 results, recommend dividend and bonus shares (subject to approval), potential multi-faceted capital return

Scheduled Board meeting May 2, 2026 for standalone/consolidated audited Q4/FY26 results and dividend recommendation, early catalyst compliance with SEBI Reg 29

98.17% favorable votes (4,790,179,506 votes) for independent director re-appointment via e-voting (turnout 56.73%), vs 1.83% against, strong governance conviction

17 outstanding NCDs all rated AA+ Stable or AAA Stable (CRISIL/ICRA/others verified early 2026), 100% timely interest/redemptions in FY26, robust debt profile

Allotted 3,001,435 equity shares (Rs. 2 FV) under ESOP-2000 on April 17, 2026, approved by delegated directors, aligns employee incentives with growth

Trading window reopens April 30, 2026 post-April 27 meeting (closed since March 27), disciplined insider trading compliance per SEBI PIT Regs

Trading window closed from April 1, 2026 reopening 48 hours post-May 2 results, stringent UPSI management across BSE/NSE scrips

Postal ballot resolution passed April 17, 2026 with scrutinizer report, high approval on 56.73% turnout of 8.6B shares signals board stability

New FY26 NCD issuances (# marked) received strong ratings, some prior issuances (* marked) matured/called without issues, funding flexibility

ESOP allotment at 11:52 a.m. April 17, 2026 via October 21, 2023 board delegation, efficient execution minimizes dilution impact

2/5 filings (40%, first 2 new) flag imminent results/dividends vs prior briefs' context, accelerating sector catalyst calendar

Record date March 13, 2026 for e-voting, swift execution from Jan 31 scrutinizer appointment enhances credibility

Closed since April 1, 2026 until 48hrs post-May 2 results across 6 BSE scrips, restricts liquidity and signals pending material info

Potential bonus declaration on April 27 subject to shareholder approval, equity dilution risk despite dividend offset

3,001,435 new shares allotted April 17, incremental dilution under ESOP-2000, monitor cumulative impact vs market cap

56.73% participation (4.88B polled of 8.6B shares), 43% abstention may indicate shareholder apathy

Some of 17 NCDs (*) matured or call exercised in FY26, potential refinancing needs despite no defaults

Materiality 8/10 but neutral tone on pre-results filing, no forward guidance, uncertainty on FY26 dividend yield

Window shut since March 27 intimation, prolonged restriction vs peers heightens pre-April 27 volatility

40% constituents with near-term results (Apr 27/May 2), risk of misses propagating to index rotation

Ongoing allotments (post-Oct 2023 delegation), watch for acceleration signaling higher burn rate

Positive ratings but no operational metrics/period trends, limited alpha without FY26 results context

Board approval April 27, 2026 for FY26 payout/bonus, potential yield boost vs historical norms

May 2, 2026 meeting for Q4/FY26 audited results + dividend, position for beat on deposit/lending trends

98.17% re-appointment approval bolsters independent oversight, attractive for long-term stability play

AAA/AA+ on all 17 NCDs (no defaults FY26), undervalued funding cost edge vs private peers

ESOP allotment of 3M shares reflects management confidence, buy on human capital moat

Accumulate post-April 30, 2026 if results positive, liquidity unlock after closure

Dividend recommendation on May 2 amid SEBI compliance, historical payout growth opportunity

High 98% support on 56% turnout, consolidation play ahead of next AGM

Strong ratings verified early 2026, pair with equity for yield enhancement

New filings (3/5) signal sector momentum, overweight vs broader Nifty ahead of late April catalysts

2/5 BANKEX filings (City Union Apr 27, Kotak May 2) as new triggers, 40% early reporters vs prior briefs, sets Q4/FY26 tone for index [IMPLICATION: Volatility but upside skew]

Dividends on agenda for 2/5 (Kotak/City Union), bonus potential at City, YoY pattern of shareholder focus amid no buyback mentions [IMPLICATION: Yield appeal in rate cut cycle]

All 5 cite SEBI LODR/PIT regs (29/50/60), IDFC 98% approval outlier, trading windows closed/reopening managed [IMPLICATION: Low regulatory risk, high discipline]

Canara's 17 NCDs at AA+/AAA (100% timely FY26), no sector-wide distress signals [IMPLICATION: Stable funding supports NIM expansion]

3 neutral (results/ESOP), 2 positive (governance/debt), materiality avg 6.2/10, no bearish flags [IMPLICATION: Base case stability, catalysts to differentiate]

No pledges/sells reported, ESOP allotment only positive alignment, trading windows enforce discipline across 5 firms [IMPLICATION: Management conviction intact pre-results]

Q4/FY26 results, dividend, bonus approval - April 27, 2026; flag guidance changes or payout surprises

Audited standalone/consolidated results + dividend - May 2, 2026; monitor YoY metrics post-release

Reopens April 30, 2026; watch insider buys post-results for conviction signal

Reopens 48hrs after May 2 declaration; track volume spikes for sentiment

Re-appointed Mr. S. Ganesh Kumar (DIN 07635860); monitor board contributions in next filings

Ongoing allotments under 2000 scheme; watch cumulative shares vs FY26 EPS dilution

Interest/redemption record dates (per Reg 60); flag any rating changes or new issuances

Post-April 27/ May 2 outcomes; monitor peer reactions for rotation into/out of BANKEX